The electronic nose: emerging biomarkers in lung cancer diagnostics

Lung cancer is very common and the most common cause of cancer death worldwide. Despite recent progress in the systemic treatment of lung cancer (checkpoint inhibitors and tyrosine kinase inhibitors), each year, >1.5 million people die due to this disease. Most lung cancer patients already have a...

Descripción completa

Detalles Bibliográficos
Autores principales: van Geffen, Wouter H., Lamote, Kevin, Costantini, Adrien, Hendriks, Lizza E.L., Rahman, Najib M., Blum, Torsten G., van Meerbeeck, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121878/
https://www.ncbi.nlm.nih.gov/pubmed/32280381
http://dx.doi.org/10.1183/20734735.0309-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121878/
https://www.ncbi.nlm.nih.gov/pubmed/32280381
http://dx.doi.org/10.1183/20734735.0309-2019

Ejemplares similares